Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent

Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent

US Patent 8318663 · Granted Nov 27, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bile acid recycling inhibitors for treatment of pediatric cholestatic liver dise2025
Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic li2024
Glucagon-receptor selective polypeptides and methods of use thereof2023
Methods comprising continuous administration of exenatide and co-administration 2023
Bile acid recycling inhibitors for treatment of pediatric cholestatic liver dise2022
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity,2022
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity,2022
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity,2022
Bile acid recycling inhibitors for treatment of pediatric cholestatic liver dise2022
Glucagon-receptor selective polypeptides and methods of use thereof2022
Detection of rare sequence variants, methods and compositions therefor2021
Methods comprising continuous administration of a GLP-1 receptor agonist and co-2020